Aarden Pharmaceuticals is a small molecule drug discovery and development company. The company’s novel technology is a chemistry breakthrough that will enable it to make drugs against a previously un-druggable set of intracellular phosphatase (PTP) disease targets. The technology was developed in the laboratory of Dr. Zhong-Yin Zhang, Robert A. Harris Professor and chairman of biochemistry and molecular biology at the Indiana University School of Medicine. Zhang is an internationally recognized expert in the field of protein tyrosine phosphatases (PTPs). Aarden’s first programs are focused on infectious disease, cancer, and metabolic and autoimmune conditions.
ApeX Therapeutics is a biotechnology company focused on the discovery, development, and commercialization of novel pharmaceuticals for the treatment of cancer and age-related macular degeneration. The company’s scientific founder, Professor Mark R. Kelley, and the team at his laboratory at the Indiana University School of Medicine identified rationale for targeting the APE1/Ref-1 redox signaling and DNA repair protein for the development of drugs to treat cancer.
Courseload is a new digital platform that delivers course materials through web-enabled devices. This product delivers the same course material as traditional textbooks at about one third of the cost, thus reducing costs for students. Courseload was designed and piloted at IU, and IU has signed a deal with Courseload to make this option available to all IU students. Many other educational institutions are making Courseload available to students as well.
Cause.it is web data platform that enables nonprofits to connect to volunteers and businesses natively over a free-to-user mobile application. Users are able to find new volunteer and social good opportunities in their local communities and participate in helping nonprofits that they care about. Users are then able to redeem points they earn through social activitism with big brands for awesome gifts and rewards. Meanwhile nonprofits learn about new volunteers and donors in their area and enable them to help promote their Causes.
Diagnotes™ allows providers and patients to connect with on-call providers while simultaneously delivering key patient information from the EMR to the point of care. From the initial inbound call or secure text message through documentation of the completed encounter and support for follow-up actions, Diagnotes seamlessly delivers a fully integrated, closed-loop solution that readily integrates into current clinical practices.